# Isagawa Launch Roadmap

**Version:** 2.0
**Created:** 2026-01-05
**Last Updated:** 2026-01-11
**Status:** 4-Product Launch Strategy

---

## Overview

**Strategic Insight (2026-01-11):** Based on fresh competitive intelligence, Isagawa is launching four products in sequence to maximize market opportunity and minimize competitive risk.

**Launch Sequence:**
1. **QA Management Engine** (Week 1) - Open source, community flywheel, brand building
2. **Consumer Execution Engine** (Weeks 2-8) - User-configurable, no SME needed, brand positioning trap advantage
3. **AI Agent Management Layer** (Weeks 9-16) - Dogfooding on our own testing agents, validates platform thesis
4. **Enterprise via Compliance** (Parallel) - EU AI Act August 2026 deadline (6 months)
5. **Healthcare Vertical** (Later) - Requires SME, lower urgency

**Rationale:**
- QA establishes brand + "Isagawa pattern" as THE STANDARD for AI test automation
- Consumer capitalizes on 18-24+ month window (brand positioning trap: LLM vendors can't add enforcement without admitting models are unreliable)
- Agent Management validates platform thesis via dogfooding (10-20x bigger market than QA alone, 40% project failure rate creates demand)
- Enterprise captures EU AI Act compliance urgency (August 2026 deadline = 6 months)
- Healthcare deferred until SME recruited

**Reference:** See `.business/intel_reports/competitive_intel_consolidated_2026-01-11.md` for full competitive analysis

---

## PHASE 1: QA MANAGEMENT ENGINE (OPEN SOURCE) 🔄 IN PROGRESS

**Timeline:** Week 1
**Goal:** Open source launch with dual GTM (community + enterprise tier)
**Current Status:** Defect fixes in progress

**Strategic Positioning:**
- **Public message:** "AI-powered test automation that generates professional, maintainable code you own"
- **Open source flywheel:** Community ports to Playwright, Cypress, WebdriverIO → "Isagawa pattern" becomes THE STANDARD
- **Revenue model:** Free (open source) + Enterprise tier ($499-2,499/mo for compliance, support, certification)
- **Threat:** 5/10 (Virtuoso, mabl, LambdaTest) - 12-18 month window
- **Validation:** 9/10 (40% of enterprises integrating AI into CI/CD)

### Completed Work

| Project | Task | Description | Status |
|---------|------|-------------|--------|
| qa-management-engine | 1.0-15.0 | All 10 quality gates + integration tests | ✅ DONE |
| release-readiness | 1.0-3.0 | Audit Trail, Self-Heal Cap, Execution Mode, License/Docs | ✅ DONE |
| enhanced-runtime | 1.0-8.5 | Scope Discovery, RuntimeValidator, Visual Feedback, WebInterface Checker | ✅ DONE |

### In Progress

| Project | Task | Description | Status |
|---------|------|-------------|--------|
| defect-fixes | 1.0-5.0 | Two-Pass Discovery (DEF-045), Test Redundancy (DEF-046) | 🔄 IN PROGRESS |

### Remaining Phase 1 Tasks

| # | Task | Owner | Status |
|---|------|-------|--------|
| 1.1 | Complete defect fixes (DEF-045, DEF-046) | FOUNDER | IN PROGRESS |
| 1.2 | Smoke Tests (2+ sites) | FOUNDER | IN PROGRESS (retest pending) |
| 1.3 | Adversarial Tests | FOUNDER | NOT STARTED |
| 1.4 | E2E Integration Verification | FOUNDER | IN PROGRESS (retest pending) |
| 1.5 | PyPI packaging (`pip install isagawa-qa`) | FOUNDER | NOT STARTED |
| 1.6 | README quick start | FOUNDER | STARTED |
| 1.7 | Landing page (1-pager) | CMO | NOT STARTED |
| 1.8 | First user outreach (3-5 targets) | FOUNDER | NOT STARTED |

**Flow:** 1.2/1.4 found defects → 1.1 fixing → retest 1.2/1.4 → then 1.5+

---

## PHASE 2: CONSUMER EXECUTION ENGINE

**Timeline:** Weeks 2-8 (4-6 weeks build)
**Goal:** User-configurable AI rule enforcement for 100M+ ChatGPT users
**Dependencies:** Phase 1 complete

**Strategic Positioning:**
- **Product:** Users define 3-5 rules for ANY LLM task, Isagawa enforces with pre/post gates and auto-retry
- **Architecture:** `User Task + Rules → Pre-Gate (inject) → LLM → Post-Gate (validate) → Pass/Retry`
- **Target:** Process-based professionals (developers, legal, healthcare, researchers, finance) who already expect enforcement in their work
- **Threat:** 1/10 (ChatGPT Custom Instructions) - **Brand positioning trap:** LLM vendors can't add enforcement without admitting models unreliable
- **Validation:** 10/10 (100M+ weekly ChatGPT users, custom instructions frustration validated, willingness to pay proven)
- **Window:** 18-24+ months (possibly indefinite due to structural moat)

**Why This is Next:**
- No SME needed (user-configurable, users are their own experts)
- Fastest path to validate platform thesis (protocols + gates work beyond QA)
- Brand positioning trap creates structural advantage
- Shortest build time (4-6 weeks) vs Enterprise (requires generalization + compliance docs)

### Tasks

| # | Task | Owner | Dependencies | Status |
|---|------|-------|--------------|--------|
| 2.1 | Consumer product design (if needed) | FOUNDER | 1.8 | REFERENCE EXISTS |
| 2.2 | Generalize protocols from QA-specific to domain-agnostic | FOUNDER | 1.8 | NOT STARTED |
| 2.3 | Build web app UI (rule configuration, task submission) | FOUNDER | 2.2 | NOT STARTED |
| 2.4 | Implement pre-gate (rule injection) | FOUNDER | 2.2 | NOT STARTED |
| 2.5 | Implement post-gate (validation + auto-retry) | FOUNDER | 2.2 | NOT STARTED |
| 2.6 | Build rule compliance reporting ("3/3 Passed") | FOUNDER | 2.5 | NOT STARTED |
| 2.7 | Test with 3-5 use cases (writing, code, research) | FOUNDER | 2.6 | NOT STARTED |
| 2.8 | Landing page + messaging | CMO | 2.7 | NOT STARTED |
| 2.9 | Launch freemium ($0/50 calls, $49/mo unlimited) | FOUNDER + CMO | 2.8, Business Setup | NOT STARTED |

**Reference:** `.business/roadmap/ideas/generalized_quality_gates_consumer.md`, `.business/intel_reports/competitive_intel_consolidated_2026-01-11.md` (Part 3)

---

## PHASE 3: AI AGENT MANAGEMENT LAYER (DOGFOODING)

**Timeline:** Weeks 9-16 (dogfooding on own testing agents first)
**Goal:** Apply agent protocol enforcement to our own testing agents, create proof of concept
**Dependencies:** Phase 1 complete, Phase 2 launched

**Strategic Positioning:**
- **Product:** Protocol adherence enforcement for multi-step autonomous agents via mandatory quality gates
- **Dogfooding insight:** Our testing agents use protocols (guidance) but NO quality gates (enforcement) - exactly the problem we solve for others
- **Target market:** Enterprises deploying autonomous AI agents (testing, customer service, data processing, DevOps)
- **Threat:** 3/10 (AgentOps/Langfuse/Arize observability, LangGraph/CrewAI orchestration) - They monitor/coordinate, we enforce
- **Validation:** 10/10 (40% agentic AI project failure rate, $30B+ orchestration market, governance shift from optional to mandatory)
- **Window:** 18-24 months (no direct competitor in protocol enforcement category)
- **Market size:** 10-20x bigger than QA market alone

**Why Dogfooding First:**
1. Validates thesis (if we can't use our own product, how can others?)
2. Creates case study before external launch
3. Improves QA platform (more reliable testing through enforced protocols)
4. Strategic positioning (first AI Management Layer for multi-step agents)
5. Competitive moat (infrastructure + methodology + proof of concept)

### Tasks

| # | Task | Owner | Dependencies | Status |
|---|------|-------|--------------|--------|
| 3.1 | Design agent quality gates (preflight, checkpoints 1-10, completion) | FOUNDER | 1.8 | IDEA DOC EXISTS |
| 3.2 | Implement qg_test_agent_preflight | FOUNDER | 3.1 | NOT STARTED |
| 3.3 | Implement qg_test_agent_protocol_adherence | FOUNDER | 3.1 | NOT STARTED |
| 3.4 | Implement qg_test_agent_checkpoint_1 through checkpoint_10 | FOUNDER | 3.1 | NOT STARTED |
| 3.5 | Implement qg_test_agent_completion | FOUNDER | 3.1 | NOT STARTED |
| 3.6 | Update testing protocol with gate enforcement | FOUNDER | 3.5 | NOT STARTED |
| 3.7 | Sub-agent execution wrapper that enforces gates | FOUNDER | 3.6 | NOT STARTED |
| 3.8 | Validate agent cannot bypass checkpoints | FOUNDER | 3.7 | NOT STARTED |
| 3.9 | Run 5+ test scenarios with agent gates enabled | FOUNDER | 3.8 | NOT STARTED |
| 3.10 | Document dogfooding case study | CMO | 3.9 | NOT STARTED |

**Reference:** `.business/roadmap/ideas/ai_agent_management_layer_vertical.md`, `.business/intel_reports/competitive_intel_consolidated_2026-01-11.md` (Part 4)

**Note:** External launch (Phase 3B) comes after dogfooding validates product-market fit. Pricing: $199/mo (Starter), $999/mo (Pro), $2,499-10K/mo (Enterprise).

---

## PHASE 4: BUSINESS FOUNDATION (PARALLEL WITH PHASES 1-3)

**Goal:** Legitimate entity ready to accept payment

**Note:** This runs in parallel with product development phases

| # | Task | Owner | Dependencies | Status |
|---|------|-------|--------------|--------|
| 4.1 | Register LLC (Isagawa Corp LLC) | CMO | None | NOT STARTED |
| 4.2 | Buy domains (isagawacorp.com + alternates) | CMO | None | NOT STARTED |
| 4.3 | Open business bank account | CMO | 4.1 | NOT STARTED |
| 4.4 | Set up Stripe for payments | CMO | 4.3 | NOT STARTED |
| 4.5 | Set up email (founders@isagawacorp.com) | CMO | 4.2 | NOT STARTED |
| 4.6 | Terms of service / license finalization | FOUNDER | 4.1 | STARTED (LICENSE.md) |

### Decisions Made

**Entity Type:** LLC
- Simpler structure for bootstrap phase
- Pass-through taxation
- Plan to convert to Corp later (hence "Isagawa Corp" naming)

**Domain Strategy:**

| Domain | Purpose | Status |
|--------|---------|--------|
| isagawa.com | Ideal | TAKEN |
| **isagawaco.com** | Primary for LLC (DBA: Isagawa Co.) | TO BUY |
| isagawacorp.com | Future (after Corp conversion) | TO BUY |
| isagawa.ai | Alternative | TO CHECK |
| isagawa.io | Alternative | TO CHECK |

**Note:** LLC formation won't allow "Corp" in name. Use DBA "Isagawa Co." until Corp conversion.

**Product Model (from Platform Pack Architecture):**

```
ISAGAWA CORE PLATFORM (100% Isagawa revenue)
├── Quality Gates Engine
├── Enforcement runtime
├── Escalation & human handoff
├── Audit & traceability
└── Pack runtime & versioning
        │
        ▼
PACKS (Revenue shared with SME contributors)

QA VERTICAL:
├── Developer Packs: Test Authoring, UI Automation, API Testing
└── Admin Packs: QA Governance, Compliance & Audit, CI/CD Enforcement

HEALTHCARE VERTICAL:
├── Workflow Packs: Clinical Documentation, Handoff/Transitions, Compliance Checklists
└── (Pack determined after SME discovery)
```

**Revenue Model:**

| Component | Revenue |
|-----------|---------|
| Platform license | 100% Isagawa |
| Packs | Shared with contributing SME(s) |
| Custom services | Isagawa-led |

**Distribution (Tech/QA):**
- Bottom-up: pip install, GitHub, docs
- Sales: Platform license + pack expansion
- Motion: Developers adopt → org formalizes

**Reference:** See `Isagawa_Platform_Pack_Architecture.md` for full details

---

## PHASE 5: ENTERPRISE VIA COMPLIANCE (PARALLEL)

**Timeline:** Parallel with Phases 1-3, EU AI Act deadline August 2, 2026 (6 months)
**Goal:** Enterprise AI Management Layer via compliance wedge
**Dependencies:** Phases 1-3 progress (can start immediately with compliance positioning)

**Strategic Positioning:**
- **Product:** Horizontal AI Management Layer for enterprises (pre-execution checks, mid-execution gates, human escalation triggers)
- **Entry wedge:** EU AI Act compliance (August 2026 deadline creates urgency)
- **Target:** Enterprises deploying agentic AI at scale (healthcare, finance, construction, legal, insurance)
- **Threat:** 4/10 (Google Vertex AI, Credo AI, Kore.ai) - Real threat, 12-18 month window
- **Validation:** 10/10 (40% agentic AI project failure, EU AI Act deadline, 80% ungoverned, $7.8B→$52.6B market 2025-2030)
- **Window:** 12-18 months before hyperscalers add governance features

**Why Parallel:**
- EU AI Act August 2026 deadline = 6 months (can't wait for Phases 1-3 to complete)
- Requires: Generalize protocols/gates from QA + build compliance documentation
- Build time: 3-5 weeks (faster than Consumer because just generalizing existing gates)
- Can position with QA case study even before full product ready

### Tasks

| # | Task | Owner | Dependencies | Status |
|---|------|-------|--------------|--------|
| 5.1 | Generalize quality gates from QA-specific to domain-agnostic | FOUNDER | Phase 1 progress | NOT STARTED |
| 5.2 | Design horizontal gate framework (any agent, any domain) | FOUNDER | 5.1 | NOT STARTED |
| 5.3 | EU AI Act compliance documentation package | CMO + FOUNDER | 5.2 | NOT STARTED |
| 5.4 | Build enterprise UI/middleware integration layer | FOUNDER | 5.2 | NOT STARTED |
| 5.5 | HITL enforcement (DD-22) packaging for compliance | FOUNDER | 5.2 | NOT STARTED |
| 5.6 | Progressive audit trail for 3+ year record-keeping | FOUNDER | 5.2 | EXISTS (from QA) |
| 5.7 | Enterprise landing page + compliance webinar series | CMO | 5.3 | NOT STARTED |
| 5.8 | Target healthcare (18% have governance) + finance | FOUNDER + CMO | 5.7 | NOT STARTED |
| 5.9 | Fast-track compliance package "EU AI Act Ready in 90 Days" | FOUNDER + CMO | 5.3 | NOT STARTED |
| 5.10 | First 3 enterprise customers ($25K MRR target) | FOUNDER | 5.9 | NOT STARTED |

**Pricing:** $2,499-10K/mo (enterprise licensing, audit trails, compliance reporting, SLA)

**GTM by Vertical:**
- **Healthcare:** "EU AI Act compliance in 90 days. August deadline is 6 months away."
- **Finance:** "Human-in-the-loop is now mandatory. We enforce it."
- **Construction:** "Safety-critical workflows need absolute control. We provide it."
- **Legal:** "Client privilege requires execution governance. We guarantee it."

**Reference:** `.business/intel_reports/competitive_intel_consolidated_2026-01-11.md` (Part 1)

---

## PHASE 6: HEALTHCARE VERTICAL (DEFERRED)

**Timeline:** After SME recruited (lower urgency than other products)
**Goal:** Healthcare-specific execution engine via Pack Contributor SME
**Dependencies:** Platform validated (Phases 1-3), SME recruited

**Why Deferred:**
- Requires Pack Contributor SME (domain expertise needed)
- Consumer/Agent Management don't require SME (faster to market)
- Platform must be proven before recruiting SMEs
- No urgent regulatory deadline (unlike Enterprise EU AI Act)

**When to Start:** After Phase 3 dogfooding validates platform thesis + SME recruited

### Tasks (When Ready)

| # | Task | Owner | Dependencies | Status |
|---|------|-------|--------------|--------|
| 6.1 | Healthcare workflow research | FOUNDER | Platform validated | NOT STARTED |
| 6.2 | Engage nurse consultant as Pack Contributor | FOUNDER | 6.1 | NOT STARTED |
| 6.3 | SME partnership agreement (revenue share) | FOUNDER + CMO | 6.2 | NOT STARTED |
| 6.4 | Define healthcare-specific Design Decisions | FOUNDER + SME | 6.3 | NOT STARTED |
| 6.5 | Build thin web front-end for non-tech users | FOUNDER | 6.4 | NOT STARTED |
| 6.6 | Build first Healthcare Pack | FOUNDER | 6.5 | NOT STARTED |
| 6.7 | Healthcare quality gates | FOUNDER | 6.6 | NOT STARTED |
| 6.8 | Healthcare pilot user (hospital/clinic) | FOUNDER + CMO | 6.7 | NOT STARTED |
| 6.9 | Healthcare case study | CMO | 6.8 | NOT STARTED |

**SME Network:** Nurse consultant (cousin), ER/OR nurses, respiratory tech, radiology tech, podiatrist
**Pack candidates:** Clinical Documentation, Handoff/Transitions, Compliance Checklists

**Reference:** `.business/roadmap/references/healthcare_sme_engagement.md`, `Isagawa Domain Expansion Model.md`

---

## PHASE 7: CATEGORY CREATION & FIRST REVENUE (ONGOING)

**Goal:** Free users → paid conversion + category authority across all products
**Timeline:** Ongoing throughout Phases 1-6

### Parallel Tracks

```
FOUNDER (Product/Sales):          CMO (Category/Content):
├── User outreach                 ├── Product onboarding
├── Beta onboarding               ├── Category-defining content
├── Feedback collection           ├── LinkedIn/distribution
├── Iterate product               ├── Case studies from results
└── Convert to paid               └── Authority building
```

### Category-Defining Content

**Core Message:** "AI Governance vs AI Execution Management: Why Monitoring Isn't Enough"

| What Others Build | What Isagawa Builds |
|-------------------|---------------------|
| Monitors AI behavior | Controls AI behavior |
| Documents compliance | Enforces compliance |
| Alerts on violations | Prevents violations |
| Audits after execution | Gates during execution |
| *"Did the AI do it right?"* | *"The AI can only do it right"* |

**Distribution:**
- LinkedIn articles (CMO)
- Blog posts (isagawaco.com)
- Landing page manifestos
- Case studies from each vertical
- ProductHunt launches (QA, Consumer, Agent Management, Enterprise)

**Target Communities:**
- QA: r/QualityAssurance, r/softwaretesting, TestGuild
- Consumer: r/ChatGPT, r/ClaudeAI, r/LLMs
- Agent Management: r/LangChain, r/MachineLearning, AI agent communities
- Enterprise: LinkedIn (CTO, VP Engineering, Compliance Officers)

**Reference:** See CMO brief below for full category content strategy

---

### CMO BRIEF: Category-Defining Content

**Why This Matters**

This is about **creating a new market category** rather than competing in an existing one.

**The Problem with Competing:**

If we say: *"Isagawa is an AI governance tool"*
- We compete with Credo AI, Holistic AI, IBM, etc.
- We're a small player in their category
- They define the rules

**The Power of Category Creation:**

If we say: *"AI Governance is the wrong approach. Here's why."*
- We CREATE a new category: **AI Execution Management**
- We define what it means
- Competitors are now playing catch-up in OUR category

---

**THE ONE PIECE OF CONTENT TO CREATE**

**Title:** "AI Governance vs AI Execution Management: Why Monitoring Isn't Enough"

**Structure:**
1. **The problem:** AI is doing real work now (not just answering questions)
2. **The current solution:** AI Governance (monitoring, compliance, documentation)
3. **Why it fails:** Watching AI work ≠ controlling how it works. Auditing after the fact ≠ preventing errors.
4. **The new category:** AI Execution Management (enforce, gate, escalate at runtime)
5. **The shift:** From "Did the AI do it right?" to "The AI can only do it right"
6. **Who's building this:** Isagawa

**Key Messaging:**

| AI Governance (What Others Build) | AI Execution Management (What Isagawa Builds) |
|-----------------------------------|----------------------------------------------|
| Monitors AI behavior | Controls AI behavior |
| Documents compliance | Enforces compliance |
| Alerts on violations | Prevents violations |
| Audits after execution | Gates during execution |
| *"Did the AI do it right?"* | *"The AI can only do it right"* |

**Format Options:**
- Blog post (primary)
- LinkedIn article
- Landing page manifesto

**Effect:** Everyone who reads it sees the world through OUR lens. Governance = old. Execution Management = new. Isagawa = the leader.

---

**Reference Documents for CMO:**
- `isagawa_corp_thesis_v3.1.md` - Full company thesis and positioning
- `Isagawa_Platform_Pack_Architecture.md` - Product model (Platform + Packs)
- `isagawa_marketing_brief_v3.0.md` - Marketing positioning
- `competitive_intel_consolidated_2026-01-11.md` - Latest competitive landscape (4 products)

---

## Dependencies & Timeline

```
WEEK 1: PHASE 1 (QA Open Source)
├── 1.5 PyPI ──► 1.6 README ──► 1.7 Landing ──► 1.8 First User
│
├─► PHASE 4 (Business) ◄──── PARALLEL ────────────────────────┐
│   ├── 4.1 LLC ──► 4.2 Domain ──► 4.3 Bank ──► 4.4 Stripe   │
│   └── 4.6 Terms of Service                                  │
│                                                              │
WEEKS 2-8: PHASE 2 (Consumer)                                  │
├── 2.2 Generalize protocols                                   │
├── 2.3 Web app UI                                             │
├── 2.4-2.6 Pre/post gates + reporting                         │
└── 2.9 Launch freemium ◄─────────────────────────────────────┤
    │                                                           │
WEEKS 9-16: PHASE 3 (Agent Management - Dogfooding)            │
├── 3.1-3.5 Implement agent quality gates                      │
├── 3.6-3.8 Sub-agent wrapper + enforcement                    │
└── 3.10 Case study                                            │
    │                                                           │
PARALLEL: PHASE 5 (Enterprise via Compliance) ◄────────────────┤
├── 5.1-5.2 Generalize gates (horizontal)                      │
├── 5.3 EU AI Act compliance docs                              │
├── 5.4 Enterprise UI/middleware                               │
└── 5.9-5.10 First 3 enterprise customers ($25K MRR)           │
    │                                                           │
ONGOING: PHASE 7 (Category Creation & Revenue) ◄───────────────┤
├── Content creation (CMO)                                     │
├── User outreach + onboarding                                 │
├── Free → paid conversion                                     │
└── Case studies per product                                   │
    │                                                           │
LATER: PHASE 6 (Healthcare - DEFERRED) ◄───────────────────────┘
├── After platform validated + SME recruited
└── 6.1 Research ──► 6.2 SME ──► 6.4 DDs ──► 6.6 Pack ──► 6.8 Pilot
```

**Critical Path:** Phase 1 → Phase 2 → Phase 3 (sequential, 16 weeks total)
**Parallel Path:** Phase 4 (Business), Phase 5 (Enterprise), Phase 7 (Category/Revenue)
**Deferred:** Phase 6 (Healthcare) until SME recruited

---

## Open Questions

### Resolved
- [x] LLC or C-Corp? → **LLC** (convert to Corp later)
- [x] Pricing model? → **Platform + Packs + Freemium** (see Platform Pack Architecture)
- [x] Domain name? → **isagawaco.com** (primary for LLC/DBA), isagawacorp.com (future Corp)
- [x] Product launch sequencing? → **QA → Consumer → Agent Management → Enterprise** (see competitive intel 2026-01-11)
- [x] Healthcare timing? → **DEFERRED** until platform validated + SME recruited (lower urgency than other products)

### Open
- [ ] Which Healthcare Pack to start with? (Wound Care recommended - discuss with nurse consultant when ready)
- [ ] Enterprise compliance documentation scope? (EU AI Act only vs multi-jurisdiction)
- [ ] Agent Management external launch timing? (After dogfooding validates, or wait for customer demand?)

---

## Revision History

| Version | Date | Changes |
|---------|------|---------|
| 1.0 | 2026-01-05 | Initial roadmap created, Phase 1 marked complete |
| 1.1 | 2026-01-06 | Added owner assignments (FOUNDER/CMO), Platform+Pack pricing model, CMO brief for category content, expanded Phase 4 Healthcare with Pack candidates and SME model |
| **2.0** | **2026-01-11** | **MAJOR RESTRUCTURE:** 4-product launch strategy based on competitive intel. Phase 1: QA Open Source (week 1). Phase 2: Consumer (weeks 2-8, user-configurable, brand positioning trap). Phase 3: AI Agent Management Layer (weeks 9-16, dogfooding). Phase 4: Business Foundation (parallel). Phase 5: Enterprise via Compliance (parallel, EU AI Act urgency). Phase 6: Healthcare (deferred until SME recruited). Phase 7: Category Creation ongoing. Updated dependencies, timelines, strategic positioning per product. Reference: `.business/intel_reports/competitive_intel_consolidated_2026-01-11.md` |

---

*This document is the master launch roadmap. Update as phases complete.*
